Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02343939
Title Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications

acute myeloid leukemia

Therapies

Decitabine

Cytarabine + Daunorubicin

Entospletinib

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
UCLA Los Angeles California United States Details
University of Chicago Chicago Illinois United States Details
Loyola University Medical Center Maywood Illinois United States Details
Indiana University Indianapolis Indiana United States Details
University of Kansas Medical Center Research Institute, Inc Fairway Kansas United States Details
Dana Farber Cancer Institute Boston Massachusetts United States Details
Henry Ford Health System Detroit Michigan United States Details
Karmanos Cancer Institute Detroit Michigan United States Details
Weill Cornell Medical College - New York - Presbyterian Hospital New York New York United States Details
Duke Cancer Center Durham North Carolina United States Details
University Hospitals Case Medical Center Cleveland Ohio United States Details
Ohio State University Columbus Ohio United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Saint Francis Cancer Center Greenville South Carolina United States Details
Princess Margaret Toronto Ontario Canada Details
Jewish General Hospital Montreal Quebec Canada Details
Universitätsklinikum Frankfurt Medizinische Klinik II Frankfurt 60590 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field